Double-blind placebo-controlled trial of erythromycin in the treatment of clinical campylobacter infection

In a double-blind placebo-controlled trial in patients hospitalized with campylobacter infection, erythromycin lessened pain and curtailed the carriage state but otherwise did not alter the natural course of the illness, which proved to be a short-lived, self-limiting one, even in this selected grou...

Full description

Saved in:
Bibliographic Details
Published inJournal of antimicrobial chemotherapy Vol. 13; no. 6; p. 619
Main Authors Mandal, B K, Ellis, M E, Dunbar, E M, Whale, K
Format Journal Article
LanguageEnglish
Published England 01.06.1984
Subjects
Adolescent
Adult
Aged
Campylobacter Infections - drug therapy
Child
Child, Preschool
Clinical Trials as Topic
Diarrhea - drug therapy
Double-Blind Method
Erythromycin - therapeutic use
Female
Humans
Infant
Male
Middle Aged
Random Allocation
Online AccessGet more information

Cover

More Information
Summary:In a double-blind placebo-controlled trial in patients hospitalized with campylobacter infection, erythromycin lessened pain and curtailed the carriage state but otherwise did not alter the natural course of the illness, which proved to be a short-lived, self-limiting one, even in this selected group of hospitalized patients; the majority had become asymptomatic by the time of the bacteriological diagnosis. The rarity of bacteraemia is highlighted by the study.
ISSN:0305-7453
DOI:10.1093/jac/13.6.619